Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...
Scientists hoping to discover better ways to boost immune function — which could lengthen our healthspan and protect immunocompromised patients — may have a new target, according to findings published ...
TECregen seed funding supports the development of thymus regeneration biologics designed to restore immune function and ...
The thymus is a specialised primary lymphoid organ that underpins the development and education of T cells. Here, immature progenitors undergo a tightly regulated series of events that not only ...
HOUSTON, June 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (FBLG), ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback